HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emma Dean Selected Research

berzosertib

4/2022Phase 1b study of berzosertib and cisplatin in patients with advanced triple-negative breast cancer.
1/2022A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer.
1/2021Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emma Dean Research Topics

Disease

20Neoplasms (Cancer)
02/2024 - 04/2009
15Ataxia Telangiectasia (Louis Bar Syndrome)
02/2024 - 01/2020
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 04/2009
6Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 02/2010
4Melanoma (Melanoma, Malignant)
02/2024 - 04/2009
4Breast Neoplasms (Breast Cancer)
04/2021 - 04/2009
3Lung Neoplasms (Lung Cancer)
02/2024 - 11/2016
3Ovarian Epithelial Carcinoma
11/2021 - 02/2010
2Inflammation (Inflammations)
11/2023 - 01/2018
2Hypophosphatemia
01/2019 - 04/2009
2Febrile Neutropenia
01/2019 - 09/2017
2Thrombocytopenia (Thrombopenia)
09/2017 - 04/2009
1Bites and Stings (Sting)
12/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2023
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023
1Triple Negative Breast Neoplasms
04/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Peripheral Nervous System Diseases (PNS Diseases)
04/2021
1Alopecia (Baldness)
04/2021
1Fatigue
04/2021
1Nausea
04/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Chromosome Aberrations (Chromosome Abnormalities)
01/2020
1Genomic Instability
11/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Fever (Fevers)
01/2019
1Neutropenia
01/2019
1Stomatitis
01/2019
1Mucositis
01/2019
1Esophagitis
01/2018
1Carcinogenesis
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Epistaxis (Nosebleed)
09/2017
1Lethargy
09/2017
1Colorectal Neoplasms (Colorectal Cancer)
02/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2009
1Circulating Neoplastic Cells
04/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2009
1Lymphoma (Lymphomas)
04/2009

Drug/Important Bio-Agent (IBA)

13ceralasertibIBA
02/2024 - 01/2020
11olaparibIBA
10/2023 - 06/2015
9Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2023 - 06/2015
7Biomarkers (Surrogate Marker)IBA
02/2024 - 02/2010
7Proteins (Proteins, Gene)FDA Link
12/2023 - 11/2020
7Phosphotransferases (Kinase)IBA
01/2023 - 01/2018
6PlatinumIBA
02/2024 - 09/2017
5Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2023 - 06/2015
3durvalumabIBA
02/2024 - 01/2022
3berzosertibIBA
04/2022 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
04/2022 - 09/2017
2VX (EDIM)IBA
01/2022 - 01/2021
2GemcitabineFDA Link
01/2022 - 09/2017
2Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2021
2Carboplatin (JM8)FDA LinkGeneric
10/2021 - 09/2017
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2021 - 11/2020
2vistusertibIBA
01/2019 - 08/2015
2Capsules (Microcapsules)IBA
01/2018 - 06/2015
2AZD 6244IBA
09/2017 - 11/2016
1Interferon Type IIBA
02/2024
1Immune Checkpoint InhibitorsIBA
12/2023
1DNA-Activated Protein KinaseIBA
08/2023
1acalabrutinibIBA
01/2023
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2023
1Protein Kinase InhibitorsIBA
01/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Etoposide (VP 16)FDA LinkGeneric
12/2021
1taxaneIBA
04/2021
1TVB-2640IBA
04/2021
1Fatty Acid Synthases (Fatty Acid Synthase)IBA
04/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1AZD7648IBA
11/2019
1Transaminases (Aminotransferases)IBA
01/2019
1Alanine Transaminase (SGPT)IBA
01/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2019
1SolutionsIBA
01/2019
1Sirolimus (Rapamycin)FDA Link
01/2019
1tisotumab vedotinIBA
01/2019
1Fibroblast Growth Factor 7FDA Link
01/2018
1TabletsIBA
01/2018
1proto-oncogene proteins pimIBA
01/2018
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2018
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2018
1AZD1208IBA
01/2018
1capivasertibIBA
01/2018
1Pemetrexed (MTA)FDA Link
09/2017
1IpilimumabIBA
11/2012
1CTLA-4 AntigenIBA
11/2012
1Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2012
1human ERBB2 proteinIBA
11/2012
1pertuzumabIBA
11/2012
1Monoclonal AntibodiesIBA
11/2012
1VemurafenibIBA
11/2012
1X-Linked Inhibitor of Apoptosis ProteinIBA
04/2009
1Messenger RNA (mRNA)IBA
04/2009
1Docetaxel (Taxotere)FDA Link
04/2009

Therapy/Procedure

9Therapeutics
02/2024 - 02/2010
7Drug Therapy (Chemotherapy)
12/2023 - 04/2009
4Immunotherapy
02/2024 - 11/2012
2Radiotherapy
01/2024 - 01/2018
1Intravenous Infusions
04/2009